Bioton (LTS:0DTR) ROCE %: -2.22% (As of Mar. 2026)


LTS:0DTR Bioton SA LTS:0DTR
68 GF Score
Price zł3.43
GF Value zł4.08
! 3 Warning Signs
View Full Analysis

What is Bioton ROCE %?

Bioton LTS:0DTR 68 ROCE % is -2.22% as of Mar. 2026. GuruFocus rates LTS:0DTR with a GF Score™ of 68/100 and a GF Value™ of zł4.08. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioton's annualized ROCE % for the quarter that ended in Mar. 2026 was -2.22%.

Bioton  (LTS:0DTR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioton ROCE % Related Terms

Bioton ROCE % Historical Data

* Premium members only.

The historical data trend for Bioton's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioton ROCE % Chart

Bioton Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.85 1.90 2.34 -0.67 1.97

Bioton Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.97 3.99 4.45 2.43 -2.22
LTS:0DTR
68GF Score
Bioton SA LTS:0DTR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioton ROCE % Calculation

Bioton's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=12.902/( ( (794.138 - 143.118) + (764.562 - 102.913) )/ 2 )
=12.902/( (651.02+661.649)/ 2 )
=12.902/656.3345
=1.97 %

Bioton's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-14.652/( ( (764.562 - 102.913) + (768.527 - 112.466) )/ 2 )
=-14.652/( ( 661.649 + 656.061 )/ 2 )
=-14.652/658.855
=-2.22 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -2.22% mean?
Bioton (LTS:0DTR) has a ROCE % of -2.22% as of Mar. 2026.
Is Bioton's ROCE % too high?
Bioton's current ROCE % is -2.22%. Overall, Bioton has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Bioton's ROCE % compare to VRTX and REGN?
Bioton's ROCE % of -2.22% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Bioton's current ROCE % is -2.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioton stock overvalued right now?
Bioton (LTS:0DTR) has a current ROCE % of -2.22%. The stock's GF Value™ is zł4.08, compared to a current price of zł3.43 — trading 16% below its estimated fair value. The current ROCE % is -2.22%. Bioton's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bioton (LTS:0DTR), the current ROCE % is -2.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 16% below its estimated GF Value™ of zł4.08.

Key valuation signals for LTS:0DTR:

  • ROCE %: -2.22%
  • GF Value™: zł4.08 vs. price of zł3.43 (16% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
68GF Score

Get the complete analysis for LTS:0DTR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.08
GF Value